Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Advances in Therapy|January 24, 2022
A Review of the Unique Drug Development Strategy of Indacaterol Acetate/Glycopyrronium Bromide/Mometasone Furoate: A First-in-Class, Once-Daily, Single-Inhaler, Fixed-Dose Combination Treatment for AsthmaDominic Brittain, Peter D'Andrea, Emilie Gruen, et al.
Respiratory Medicine|March 12, 2021
Cardiovascular safety of mometasone/indacaterol and mometasone/indacaterol/glycopyrronium once-daily fixed-dose combinations in asthma: pooled analysis of phase 3 trialsEmil Scosyrev, Richard van Zyl-Smit, Huib Kerstjens, et al.
Urologic Oncology|February 2, 2015
Effectiveness and safety of extended-duration prophylaxis for venous thromboembolism in major urologic oncology surgeryJanet E Baack Kukreja, Helen R Levey, Emil Scosyrev, et al.
Clinical Pharmacology in Drug Development|February 23, 2024
Bioequivalence Between a New Omalizumab Prefilled Syringe With an Autoinjector or with a Needle Safety Device Compared with the Current Prefilled Syringe: A Randomized Controlled Trial in Healthy VolunteersRamachandra Sangana, Yan Xu, Bharti Shah, et al.
BJU International|November 26, 2010
Do mixed histological features affect survival benefit from neoadjuvant platinum-based combination chemotherapy in patients with locally advanced bladder cancer? A secondary analysis of Southwest Oncology Group-Directed Intergroup Study (S8710)Emil Scosyrev, Benjamin W Ely, Edward M Messing, et al.
The Journal of Allergy and Clinical Immunology. in Practice|June 4, 2026
Safety of remibrutinib in chronic spontaneous urticaria: a pooled analysis of REMIX-1 and REMIX-2 trialsAna Maria Giménez-Arnau, Artem Zharkov, Bin Yang, et al.
The New England Journal of Medicine|March 30, 2026
Iptacopan in IgA Nephropathy - Final 24-Month DataJonathan Barratt, Necmi Eren, Naoki Kashihara, et al.
Lancet (London, England)|November 26, 2023
Efficacy and safety of ligelizumab in adults and adolescents with chronic spontaneous urticaria: results of two phase 3 randomised controlled trialsMarcus Maurer, Luis Felipe Ensina, Ana Maria Gimenez-Arnau, et al.
Pageof 4